Your browser doesn't support javascript.
loading
Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells.
Momeny, Majid; Moghaddaskho, Farima; Gortany, Narges K; Yousefi, Hassan; Sabourinejad, Zahra; Zarrinrad, Ghazaleh; Mirshahvaladi, Shahab; Eyvani, Haniyeh; Barghi, Farinaz; Ahmadinia, Leila; Ghazi-Khansari, Mahmoud; Dehpour, Ahmad R; Amanpour, Saeid; Tavangar, Seyyed M; Dardaei, Leila; Emami, Amir H; Alimoghaddam, Kamran; Ghavamzadeh, Ardeshir; Ghaffari, Seyed H.
Afiliação
  • Momeny M; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Moghaddaskho F; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Gortany NK; Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Yousefi H; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Sabourinejad Z; Deparmtent of Pathology, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Zarrinrad G; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mirshahvaladi S; Department of Molecular Systems Biology, Cell Science Research Centre, Royan Institute for Stem Cell Biology and Technology, Tehran, Iran.
  • Eyvani H; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Barghi F; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ahmadinia L; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghazi-Khansari M; Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Dehpour AR; Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Amanpour S; Cancer Biology Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
  • Tavangar SM; Deparmtent of Pathology, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Dardaei L; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Emami AH; Division of Oncology, Department of Internal Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Alimoghaddam K; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghavamzadeh A; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghaffari SH; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Sci Rep ; 7: 44075, 2017 03 13.
Article em En | MEDLINE | ID: mdl-28287096
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Neoplasias Encefálicas / Glioblastoma / Receptores de Fatores de Crescimento do Endotélio Vascular / Antineoplásicos Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Irã
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Neoplasias Encefálicas / Glioblastoma / Receptores de Fatores de Crescimento do Endotélio Vascular / Antineoplásicos Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Irã